Visum Pharma, Inc.
- Biotech or pharma, therapeutic R&D
VC-backed company focusing on developing novel therapies for neurodegeneration and inflammation. Its patented platform of immunomodulators acts upstream of existing therapeutic approaches and is applicable to a wide range of diseases including Alzheimer's Disease, ALS, MS, MD, Parkinson's Disease and Huntington's Disease.